Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2023-05-15
Target enrollment:
Participant gender:
Summary
This is a pilot study using [18F]F AraG PET imaging to evaluate the immunological response to
checkpoint inhibitor therapy (CkIT) in patients with advanced NSCLC tumors at multiple study
sites. The main objectives of the study are to quantify the change in [18F]F AraG PET signal
before and after CkIT therapy, and to correlate this change in [18F]F AraG PET signal with a
radiographic response.